The Role of PCR in COVID-19 Diagnostics: A Molecular and Clinical Perspective

Abstract

The COVID-19 pandemic required rapid deployment of accurate diagnostic tools to support disease detection and public health interventions. Polymerase Chain Reaction (PCR), particularly real-time reverse transcription PCR (RT-qPCR), became the gold standard for detecting COVID-19 due to its high sensitivity and specificity in identifying viral RNA (Corman et al., 2020).

This article reviews the molecular principles of PCR, its clinical workflow, diagnostic significance, limitations, and its impact on global healthcare systems during the pandemic.

Introduction

The emergence of SARS-CoV-2 in late 2019 created an urgent need for reliable diagnostic methods to enable early detection, isolation, and surveillance of infected individuals. Molecular diagnostics, particularly RT-qPCR, became the cornerstone of COVID-19 testing strategies and was recommended as the primary confirmatory method by the World Health Organization (WHO, 2020).

The rapid adoption of PCR was driven by its ability to detect viral RNA at extremely low concentrations, even in asymptomatic individuals, making it essential for controlling transmission chains.

Molecular Principle of PCR

PCR is an in vitro nucleic acid amplification technique that enables exponential replication of specific DNA sequences. In RNA viruses such as SARS-CoV-2, reverse transcription converts RNA into complementary DNA (cDNA), forming RT-PCR (Mullis and Faloona, 1987).

The amplification process consists of three repeating thermal steps:

• Denaturation (~95°C): Separation of double-stranded DNA

• Annealing (~50–65°C): Binding of sequence-specific primers

• Extension (~72°C): DNA synthesis by DNA polymerase

Diagram 1: PCR Amplification Cycle

DNA (Double Strand)

↓ Denaturation

Single Strands

↓ Annealing

Primer Binding

↓ Extension

New DNA Copies

↓

Repeated Cycles → Exponential Amplification

Real-Time RT-PCR and Quantitative Detection

Real-time RT-PCR enables simultaneous amplification and detection of target nucleic acids using fluorescent markers.

A critical diagnostic parameter is the cycle threshold (Ct) value, which represents the cycle number at which fluorescence exceeds background levels.

• Lower Ct → Higher viral load

• Higher Ct → Lower viral load

• No Ct → Negative

(Pan et al., 2020)

Diagram 2: Ct Value Concept

Fluorescence Signal

        ↑

        │            *

        │         *

        │      *

        │   *

        │ *

        └----------------------→ PCR Cycles

                 ↑

              Ct Value

Diagnostic Workflow for SARS-CoV-2 RT-qPCR

The RT-qPCR workflow involves multiple standardised steps:

4.1 Sample Collection

Nasopharyngeal or oropharyngeal swabs are collected.

4.2 RNA Extraction

Viral RNA is isolated and purified.

4.3 Reverse Transcription

RNA is converted into cDNA.

4.4 Amplification and Target Genes

Common targets include:

• N gene

• E gene

• RdRp gene

  
  

4.5 Data Interpretation

Ct values and amplification curves are analysed alongside controls (CDC, 2020).

Diagram 3: PCR Diagnostic Workflow

Patient Swab

      ↓

RNA Extraction

      ↓

Reverse Transcription

      ↓

PCR Amplification

      ↓

Fluorescence Detection

      ↓

Ct Analysis

      ↓

Diagnostic Result

Clinical Significance

RT-qPCR played a central role in global COVID-19 response strategies, extending beyond individual diagnosis to broader public health applications. It enabled early detection of infected individuals, including asymptomatic carriers, thereby facilitating timely isolation and reducing transmission.

In addition, PCR testing supported contact tracing efforts and outbreak containment measures, while also providing critical data for monitoring viral prevalence within communities. Its application in clinical settings further assisted in patient triage and resource allocation, particularly during peak infection periods.

Advantages of RT-qPCR 

RT-qPCR remains the gold standard in molecular diagnostics due to its exceptional analytical performance. It offers high sensitivity, allowing for the detection of very low viral loads, particularly during the early stages of infection. In addition, its high specificity ensures accurate targeting of SARS-CoV-2 genetic sequences, minimising the likelihood of cross-reactivity with other pathogens.

Another key advantage is its quantitative capability, as cycle threshold (Ct) values provide an indirect measure of viral load. Furthermore, the widespread standardisation of RT-qPCR protocols across laboratories enhances reproducibility and reliability, making it one of the most trusted diagnostic methods in clinical virology.

 

Limitations of PCR Testing 

Despite its diagnostic accuracy, RT-qPCR is associated with several limitations. The technique requires specialised laboratory infrastructure and highly trained personnel, which may not be readily available in all settings, particularly in low-resource environments. Additionally, the turnaround time is generally longer compared to rapid antigen tests, limiting its use in immediate screening scenarios.

There is also a risk of contamination during sample processing, which can lead to false-positive results if strict laboratory protocols are not followed. Moreover, the detection of viral RNA does not necessarily indicate active infection or infectivity, as non-viable viral fragments may still be present in recovered individuals.

Advantages vs Limitations

ADVANTAGES	LIMITATIONS
High sensitivity	Lab required
High specificity	Time-consuming
Quantitative	Contamination risk
Reliable standard	No infectivity info

Broader Impact on Biomedical Science

The widespread use of PCR strengthened global diagnostic capacity and accelerated innovation in laboratory systems.

PCR continues to play a key role in:

• Oncology

• Genetic testing

• Infectious disease diagnostics

Conclusion

RT-qPCR has fundamentally transformed infectious disease diagnostics and remains the gold standard for SARS-CoV-2 detection. Its sensitivity, specificity, and adaptability enabled rapid global response during the pandemic.

References (Harvard Style) 

CDC (2020) Real-Time RT-PCR Panel for Detection of SARS-CoV-2. Centers for Disease Control and Prevention. Available at: https://www.cdc.gov/coronavirus (Accessed: 18 April 2026). 

Corman, V.M. et al. (2020) ‘Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR’, Eurosurveillance, 25(3), pp. 1–8. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045

 Mullis, K.B. and Faloona, F.A. (1987) ‘Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction’, Methods in Enzymology, 155, pp. 335–350. 

Pan, Y. et al. (2020) ‘Viral load of SARS-CoV-2 in clinical samples’, The Lancet Infectious Diseases, 20(4), pp. 411–412. https://doi.org/10.1016/S1473-3099(20)30113-4 WHO (2020) Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. 

World Health Organization. Available at: https://www.who.int (Accessed: 18 April 2026).

---

This article was prepared by Alisha Chantru (Brunel University).

---